glp 1 from food Slideshow: GLP-1 friendly innovations on the upswing What do the new 'GLP-1
Description
Diabetes Care 1 February 2023
Write down what you eat and how you feel
The ongoing SAMAS trial (NCT05147896) will examine how oral semaglutide affects parameters of ASCVD, such as arterial stiffness, carotid intimamedia thickness and endothelial function, along with atherosclerotic risk factors (e.g., LDL-C, HbA1c, high-sensitivity CRP) [114]
1429, Westenhoefer, Joachim, et al
